BEVACIZUMAB, ERLOTINIB
Phase 3 small_molecule active
Quick answer
BEVACIZUMAB, ERLOTINIB for Non-squamous Non-small Cell Lung Cancer is a Phase 3 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Non-squamous Non-small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active